Philippines Health News API

{
    "totalArticles": 95766,
    "articles": [
        {
            "id": "0526513d5548df4f3c7bb5230864fb3d",
            "title": "Ebola deaths exceed 300 in DR Congo: Heath authorities",
            "description": "The Ebola epidemic has claimed more than 300 lives in the Democratic Republic of Congo (DRC), a little more than one month after it was declared, health authorities said Friday.",
            "content": "The Ebola epidemic has claimed more than 300 lives in the Democratic Republic of Congo (DRC), a little more than one month after it was declared, health authorities said Friday.\nThe deadly viral disease, which spreads through direct contact with bodi... [3027 chars]",
            "url": "https://medicalxpress.com/news/2026-06-ebola-deaths-exceed-dr-congo.html",
            "image": "https://scx2.b-cdn.net/gfx/news/hires/2019/ebola.jpg",
            "publishedAt": "2026-06-26T15:40:07Z",
            "lang": "en",
            "source": {
                "id": "fc12437cc984742bf9a97820262ab48a",
                "name": "Medical Xpress",
                "url": "https://medicalxpress.com"
            }
        },
        {
            "id": "ff861de55e9f7a110224d87ed31003a7",
            "title": "Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted",
            "description": "NANJING, China, June 26, 2026 /PRNewswire/ -- Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by Jiangsu Vcare PharmaTech Co.,Ltd. (Vcare PharmaTech), has been officially accepted by the NMPA. The drug has now entered the NDA stage. As a global pioneer in novel antiplatelet agents, Sumecigrel is expected to provide a new and improved treatment option to tens of millions of patients with cardiovascular and cerebrovascular diseases.",
            "content": "NANJING, China, June 26, 2026 /PRNewswire/ -- Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by Jiangsu Vcare PharmaTech Co.,Ltd. (Vcare PharmaTech), has been officially accepte... [10313 chars]",
            "url": "https://www.manilatimes.net/2026/06/26/tmt-newswire/pr-newswire/key-milestone-achieved-nda-for-sumecigrel-capsule-an-antiplatelet-innovative-drug-by-vcare-pharmatech-officially-accepted/2373798",
            "image": "https://manilatimes.net/manilatimes/uploads/images/2026/06/26/1115445.jpg",
            "publishedAt": "2026-06-26T14:57:53Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "f67cbee02e207b7c974bf6cd616efbbd",
            "title": "University of Florida Researchers Develop Rapid Urine Test for Prostate Cancer",
            "description": "Researchers have developed a rapid, noninvasive urine diagnostic test designed to identify biomarkers for prostate cancer.",
            "content": "The noninvasive method uses paper spray and mass spectrometry to identify disease biomarkers in less than 30 seconds.\nResearchers at the University of Florida have developed a rapid, noninvasive urine diagnostic test designed to identify biomarkers f... [2957 chars]",
            "url": "https://clpmag.com/disease-states/cancer/prostate/university-florida-researchers-develop-rapid-urine-test-prostate-cancer/",
            "image": "https://clpmag.com/wp-content/uploads/2026/06/image-5.png",
            "publishedAt": "2026-06-26T13:24:32Z",
            "lang": "en",
            "source": {
                "id": "393745dab7c73433069695ab3b36f967",
                "name": "Clinical Lab Products",
                "url": "https://clpmag.com"
            }
        }
    ]
}